Sugammadex versus neostigmine for reversal of neuromuscular blockade and postoperative pulmonary complications: reversal adequacy in the SNaPP pragmatic trial
British Journal of Anaesthesia · 2026-11
DOI: 10.1016/j.bja.2026.08.075 ↗Kurz gefasst
Leserbrief in der Zeitschrift British Journal of Anaesthesia, 2026-11. Verfasst von Hui Yang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anaesthesiology, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China. Die Arbeit nennt 12 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Anaesthesiology, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China.
- Department of Anaesthesiology, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China. Electronic address: sudaweijuan@163.com.
Zitieren
APA
Yang, H., Xin, Y., & Wei, J. (2026). Sugammadex versus neostigmine for reversal of neuromuscular blockade and postoperative pulmonary complications: reversal adequacy in the SNaPP pragmatic trial. British Journal of Anaesthesia. https://doi.org/10.1016/j.bja.2026.08.075
Vancouver
Yang H, Xin Y, Wei J. Sugammadex versus neostigmine for reversal of neuromuscular blockade and postoperative pulmonary complications: reversal adequacy in the SNaPP pragmatic trial. British Journal of Anaesthesia. 2026. doi:10.1016/j.bja.2026.08.075
BibTeX
@article{Yang2026,
author = {Yang, Hui and Xin, Yuqi and Wei, Juan},
title = {Sugammadex versus neostigmine for reversal of neuromuscular blockade and postoperative pulmonary complications: reversal adequacy in the SNaPP pragmatic trial},
journal = {British Journal of Anaesthesia},
year = {2026},
doi = {10.1016/j.bja.2026.08.075}
}
EUVIMED